P0562: Difference between revisions
Content added Content deleted
Michaeldakin (talk | contribs) (CSV import) |
Michaeldakin (talk | contribs) (CSV import) |
||
Line 1: | Line 1: | ||
{{Policies |
{{Policies |
||
|policyid= |
|policyid=PS086 |
||
|policy=The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
|policy=The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
||
|pcategory=Medicine |
|pcategory=Medicine |
||
|charteritem=CR001 |
|||
|keypolicyid=KP012 |
|||
|stream=Public Services |
|stream=Public Services |
||
|approval=No |
|approval=No |
Revision as of 13:37, 15 July 2021
Policy
Policy ID: | PS086 | Policy: | The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
Category: | SubCategory: | {subcategory}}} |
Description and Support Documents
Corresponding Charter Article
C1. Health
Everyone has a right to excellent medical care. A public NHS provides the most effective way of providing universal care. We guarantee a publicly owned health service and the end to privatisation.
Amendments
No results